Pazopanib Hydrochloride CAS 635702-64-6: A Key Pharmaceutical Intermediate for Advanced Cancer Treatments
Discover the pivotal role of Pazopanib Hydrochloride in modern oncology and its applications in treating complex medical conditions.
Get a Quote & SampleProduct Core Value
Pazopanib Hydrochloride
Pazopanib Hydrochloride (CAS 635702-64-6) is a crucial active pharmaceutical ingredient (API) essential for developing advanced cancer therapies. Its mechanism of action as a multi-tyrosine kinase inhibitor targets key pathways involved in tumor growth and angiogenesis, making it vital for treating conditions like advanced renal cell carcinoma and soft tissue sarcoma.
- Understanding the mechanism of action: Pazopanib Hydrochloride inhibits multiple protein tyrosine kinases, including VEGFRs, PDGFRs, and FGFRs, crucial for tumor growth and survival.
- Key applications in oncology: This API is vital for manufacturing drugs used in the treatment of advanced renal cell carcinoma and advanced soft tissue sarcoma.
- Sourcing reliable Pazopanib Hydrochloride API: Finding trustworthy Pazopanib Hydrochloride API manufacturers and suppliers is critical for ensuring product quality and therapeutic efficacy.
- The importance of CAS number 635702-64-6: This specific CAS number identifies Pazopanib Hydrochloride, ensuring accurate sourcing and regulatory compliance in the pharmaceutical industry.
Key Advantages
Targeted Cancer Therapy
Pazopanib Hydrochloride is instrumental in creating targeted cancer therapies, specifically for conditions like advanced renal cell carcinoma, offering improved patient outcomes.
Inhibits Tumor Growth Pathways
By acting as a multi-targeted tyrosine kinase inhibitor, it effectively hinders tumor growth and angiogenesis, critical for combating various cancers.
Essential Pharmaceutical Intermediate
As a vital API, Pazopanib Hydrochloride serves as a foundational component for pharmaceutical companies in their drug development pipelines.
Key Applications
Advanced Renal Cell Carcinoma Treatment
Pazopanib Hydrochloride is a cornerstone in the treatment of advanced renal cell carcinoma, a significant type of kidney cancer.
Advanced Soft Tissue Sarcoma Therapy
It plays a critical role in therapeutic regimens for advanced soft tissue sarcoma patients who have undergone prior chemotherapy.
Oncology Drug Development
Serves as a key API for research and development into new and improved oncology drugs, expanding treatment options.
Pharmaceutical Research
Utilized in research settings to understand kinase inhibition and its potential in various neoplastic conditions and drug discovery.